Chemplast Sanmar Limited
NSE:CHEMPLASTS.NS
475.2 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 49,410.8 | 49,410.8 | 58,851.08 | 37,925.97 | 12,496.09 | 12,451.91 | 30,297.549 | 29,030.088 | 26,453.035 | 22,104.471 | 21,296.976 | 18,707.732 | 9,336.835 | 6,747.802 | 6,401.787 | 6,126.257 |
Cost of Revenue
| 32,117 | 32,117 | 37,979.12 | 21,859.05 | 4,420.71 | 4,203.3 | 24,066.881 | 22,884.431 | 21,966.975 | 19,743.843 | 13,187.491 | 15,257.941 | 7,396.004 | 5,619.356 | 4,833.047 | 4,099.953 |
Gross Profit
| 17,293.8 | 17,293.8 | 20,871.96 | 16,066.92 | 8,075.38 | 8,248.61 | 6,230.668 | 6,145.657 | 4,486.06 | 2,360.628 | 8,109.485 | 3,449.791 | 1,940.831 | 1,128.446 | 1,568.74 | 2,026.304 |
Gross Profit Ratio
| 0.35 | 0.35 | 0.355 | 0.424 | 0.646 | 0.662 | 0.206 | 0.212 | 0.17 | 0.107 | 0.381 | 0.184 | 0.208 | 0.167 | 0.245 | 0.331 |
Reseach & Development Expenses
| 39.519 | 1,897.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 398.7 | 507.5 | 328.74 | 261.26 | 210.04 | 69.91 | 0 | 0 | 3.96 | 3.915 | 0 | 338.603 | 382.925 | 358.692 | 294.234 | 272.104 |
Selling & Marketing Expenses
| 417.2 | 648.8 | 546.03 | 366.54 | 189.83 | 185.28 | 0 | 0 | 568.659 | 559.286 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,472.1 | 1,515.1 | 874.77 | 627.8 | 399.87 | 255.19 | 1,042.086 | 1,242.176 | 1,455.426 | 1,148.444 | 0 | 338.603 | 382.925 | 358.692 | 294.234 | 272.104 |
Other Expenses
| 804.7 | 798.9 | 17.29 | 12.82 | 52.52 | 40.62 | 23.65 | -3.434 | 0 | -40.716 | 7,221.65 | 1,564.351 | 1,246.928 | 1,005.512 | 757.968 | 1,222.744 |
Operating Expenses
| 14,032.4 | 14,032.4 | 9,617.9 | 7,185.65 | 5,775.27 | 5,553.54 | 1,018.436 | 1,245.61 | 3,912.96 | 1,189.16 | 7,221.65 | 2,553.201 | 2,037.303 | 1,364.204 | 1,052.202 | 1,494.848 |
Operating Income
| 3,261.4 | 3,935.9 | 11,261.1 | 8,887.33 | 2,516.32 | 2,695.07 | 5,212.232 | 4,900.047 | 1,572.288 | 1,171.468 | 887.835 | 896.59 | -96.472 | -235.758 | 516.538 | 531.456 |
Operating Income Ratio
| 0.066 | 0.08 | 0.191 | 0.234 | 0.201 | 0.216 | 0.172 | 0.169 | 0.059 | 0.053 | 0.042 | 0.048 | -0.01 | -0.035 | 0.081 | 0.087 |
Total Other Income Expenses Net
| -1,546.3 | -2,220.8 | -3,305.6 | -3,417.57 | -1,799.3 | -761.08 | -1,634.547 | -1,827.357 | -1,667.209 | -1,063.743 | -1,588.836 | -1,491.796 | -1,604.139 | -754.908 | -436.528 | -209.559 |
Income Before Tax
| 1,715.1 | 1,715.1 | 7,955.46 | 5,471.91 | 717.02 | 1,933.99 | 3,577.685 | 3,072.69 | -94.921 | 107.725 | -701.001 | -595.206 | -1,700.611 | -990.666 | 80.01 | 321.897 |
Income Before Tax Ratio
| 0.035 | 0.035 | 0.135 | 0.144 | 0.057 | 0.155 | 0.118 | 0.106 | -0.004 | 0.005 | -0.033 | -0.032 | -0.182 | -0.147 | 0.012 | 0.053 |
Income Tax Expense
| 191.6 | 191.6 | 1,468.98 | 1,369.47 | 255.77 | 749.35 | 1,869.453 | 1,682.438 | 16.2 | -4.7 | -181.518 | -173.325 | -418.969 | -324.536 | 8.198 | 145.2 |
Net Income
| 1,523.5 | 1,523.5 | 6,486.5 | 4,100.85 | 461.25 | 1,184.64 | 1,786.054 | 1,502.371 | -78.721 | 119.527 | -519.483 | -421.881 | -1,281.642 | -666.13 | 71.812 | 176.697 |
Net Income Ratio
| 0.031 | 0.031 | 0.11 | 0.108 | 0.037 | 0.095 | 0.059 | 0.052 | -0.003 | 0.005 | -0.024 | -0.023 | -0.137 | -0.099 | 0.011 | 0.029 |
EPS
| 9.64 | 9.64 | 43.66 | 30.59 | 2.04 | 7.49 | 13.32 | 11.21 | -0.49 | 0.15 | -0.65 | -0.53 | -1.6 | -1.39 | 0.15 | 0.37 |
EPS Diluted
| 9.64 | 9.64 | 43.66 | 30.59 | 2.04 | 7.49 | 13.32 | 11.21 | -0.49 | 0.15 | -0.65 | -0.53 | -1.6 | -1.39 | 0.15 | 0.37 |
EBITDA
| 258.4 | 5,480.3 | 11,527.27 | 5,885.28 | 2,431.53 | 2,865.46 | 5,965.853 | 5,587.244 | 2,487.068 | 2,110.391 | 1,821.745 | 1,824.398 | 1,188.674 | 303.846 | 968.512 | 875.937 |
EBITDA Ratio
| 0.005 | 0.111 | 0.196 | 0.155 | 0.195 | 0.23 | 0.197 | 0.192 | 0.094 | 0.095 | 0.086 | 0.098 | 0.127 | 0.045 | 0.151 | 0.143 |